CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-12 | Sheena Jonathan Director | Sale 10b5-1 | −480 | $115.07 | $55K | 299,661 |
| 2024-08-12 | Sheena Jonathan Director | Sale 10b5-1 | −220 | $115.70 | $25K | 299,441 |
| 2024-08-12 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Grant or award 10b5-1 | +10,000 | 118,562 | ||
| 2024-08-08 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Exercise or conversion | +190,000 | $5.40 | $1.0M | 1,480,648 |
| 2024-08-08 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Exercise or conversion · Stock Option (right to buy) | −190,000 | 208,496 | ||
| 2024-07-31 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Exercise or conversion 10b5-1 | +100 | $5.40 | $540 | 108,562 |
| 2024-07-31 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −100 | 0 | ||
| 2024-07-31 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,866 | $99.65 | $186K | 71,955 |
| 2024-07-29 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −1,057 | $102.77 | $109K | 206,400 |
| 2024-07-29 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,196 | $102.77 | $123K | 112,441 |
| 2024-07-29 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −929 | $102.77 | $95K | 108,462 |
| 2024-07-29 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −4,084 | $102.77 | $420K | 206,293 |
| 2024-07-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,238 | $102.77 | $127K | 73,821 |
| 2024-07-26 | ROSENMAN HERM Director | Grant or award | +206 | 65,587 | ||
| 2024-07-26 | HEALY JAMES Director | Grant or award | +177 | 45,851 | ||
| 2024-07-26 | BOTHA ROELOF Director | Grant or award | +234 | 3,564 | ||
| 2024-07-26 | Baynes Roy D. Director | Grant or award | +143 | 15,683 | ||
| 2024-07-26 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −751 | $102.18 | $77K | 75,059 |
| 2024-07-25 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −690 | $105.29 | $73K | 75,810 |
| 2024-07-24 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −918 | $105.53 | $97K | 76,500 |
Page 68 of 85 · 1,682 trades